000 | 01998 a2200565 4500 | ||
---|---|---|---|
005 | 20250513113709.0 | ||
264 | 0 | _c19970401 | |
008 | 199704s 0 0 eng d | ||
022 | _a0959-8049 | ||
024 | 7 |
_a10.1016/0959-8049(95)00619-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aViscoli, C | |
245 | 0 | 0 |
_aFluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial. _h[electronic resource] |
260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cMay 1996 |
||
300 |
_a814-20 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAgranulocytosis _xcomplications |
650 | 0 | 4 |
_aAmphotericin B _xadverse effects |
650 | 0 | 4 |
_aAntifungal Agents _xadverse effects |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFever _xdrug therapy |
650 | 0 | 4 |
_aFluconazole _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunocompromised Host |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMycoses _xcomplications |
650 | 0 | 4 |
_aNeoplasms _xcomplications |
650 | 0 | 4 |
_aOpportunistic Infections _xcomplications |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aCastagnola, E | |
700 | 1 | _aVan Lint, M T | |
700 | 1 | _aMoroni, C | |
700 | 1 | _aGaraventa, A | |
700 | 1 | _aRossi, M R | |
700 | 1 | _aFanci, R | |
700 | 1 | _aMenichetti, F | |
700 | 1 | _aCaselli, D | |
700 | 1 | _aGiacchino, M | |
700 | 1 | _aCongiu, M | |
773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 32A _gno. 5 _gp. 814-20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0959-8049(95)00619-2 _zAvailable from publisher's website |
999 |
_c9066165 _d9066165 |